PURE Engagement Awards.

Pfizer secured its second consecutive win in Oncology, receiving strong feedback from AHCPs. Merck was a close runner-up in this highly competitive category.

AbbVie won the Neurology award for the second year in a row, driven by the strength of its support for its migraine therapies — the largest specialty drug area

Support for Skyrizi and Rinvoq is helping AbbVie stay ahead of the competition, earning strong feedback from both MDs and AHCPs.

AbbVie and Sanofi/Regeneron shared the win in Dermatology, with tied assessment scores that placed both programs well ahead of the rest of the field.

AbbVie is once again leading this category, driven in large part by consistently strong field ratings from both MDs and AHCPs.

Sanofi Regeneron is the new leader in this category with Dupixent, moving ahead of Merck, which is the second strongest program in the category.

Pfizer has strong name recognition and receives highly positive feedback within the hemophilia community, ahead of Genentech and Sanofi.

Pfizer is recognized for its robust oncology patient support program, known for its effective field reimbursement team that engages seamlessly with offices and provides an easy-to-use experience.

AbbVie, with its migraine-focused neurology products, is taking the top spot in neurology, previously held by MS-focused programs. A key strength lies in the team behind the program, who receive high recognition for their support.

AbbVie’s Complete program has once again been awarded best-in-class in rheumatology, distinguished by its high-quality educational materials.

Sanofi/Regeneron has won the dermatology category with its MyWay program, which receives high scores from both MDs and support staff for its effective efforts in building program awareness.

AbbVie has received its third 2024 award, winning the gastroenterology category. A key strength is its exceptional ability to deliver a superior patient experience.

AstraZeneca has won the respiratory category, a new addition to the PURE in 2024. Their strong field engagement with offices, which is highly regarded, is one of the key factors that sets them apart.

BMS is recognized as the overall best company for its portfolio of drugs in both its hematology and solid tumor offerings. Technology is one of the areas they excelled & received top scores to drive customer experience.

Genentech received top scores in every rated category from both the neurologists and their support staff. They went above & beyond to provide superior services to ensure patients can make it to & afford the treatment

AbbVie continues to receive top scores for their field engagements and are also receiving positive feedback on their educational materials used to educate the patients.

AZ improved their standings in oncology compared to previous year which in part was driven by their ability to create a strong awareness around their support offerings

Biogen gained its second consecutive win in neurology which was driven by the strong ratings from the physicians who found Biogen easy to work with

AbbVie gathered strong scores across all three sub-categories (rheumatology, dermatology, gastroenterology) with an extra credit to their field scores

Pfizer received top ratings in oncology from the support staff where its field reps and technology solutions were highlighted as top qualities.

Biogen won the first annual neurology award in part due to their dedication to go above and beyond to support their patients and work with the offices